Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1020]
News [2119]
Articles [150]
Editorials [11]
Conferences [149]
elearning [29]
The evolution of imaging techniques for multiple myeloma
Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy
The evolution of imaging techniques for multiple myeloma ( Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy )
2 May 2018
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer
Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Safety indications in mouse models treated with full doses of MEK inhibitors...
Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York...
Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099 ( Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical, New York, USA )
25 Apr 2018
A variety of approaches to measure the efficacy of PARP inhibitors
Dr Elisabetta Leo - AstraZeneca, Cambridge, UK
A variety of approaches to measure the efficacy of PARP inhibitors ( Dr Elisabetta Leo - AstraZeneca, Cambridge, UK )
25 Apr 2018
Development and clinical indications of PARP inhibitors
Dr Mark O'Connor - AstraZeneca, Cambridge, UK
Development and clinical indications of PARP inhibitors ( Dr Mark O'Connor - AstraZeneca, Cambridge, UK )
25 Apr 2018
First-in-human trial results of RET targeted BLU-667
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
First-in-human trial results of RET targeted BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018
Treating RET alterations with novel therapy BLU-667
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Treating RET alterations with novel therapy BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018
Increasing diversity through the NCI SBIR development centre
Dr Christie Canaria - National Cancer Institute, Rockville, USA
Increasing diversity through the NCI SBIR development centre ( Dr Christie Canaria - National Cancer Institute, Rockville, USA )
25 Apr 2018
Results from GOBACK: Non-chromosomal birth defects linked with cancer
Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA
Results from GOBACK: Non-chromosomal birth defects linked with cancer ( Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA )
25 Apr 2018
A link between non-chromosomal birth defects and cancer
Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA
A link between non-chromosomal birth defects and cancer ( Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA )
25 Apr 2018
How the SBIR development centre funds cancer initiatives
Michael Weingarten - National Cancer Institute, Rockville, USA
How the SBIR development centre funds cancer initiatives ( Michael Weingarten - National Cancer Institute, Rockville, USA )
25 Apr 2018
One off PSA prostate screening for men does not save lives
Prof Richard Martin - University of Bristol, Bristol, UK
One off PSA prostate screening for men does not save lives ( Prof Richard Martin - University of Bristol, Bristol, UK )
29 Mar 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation